We are live on ! Find out more
SCA

Sippican Capital Advisors Portfolio holdings

AUM $164M
1-Year Est. Return 35.17%
This Fund
S&P 500
This Quarter Est. Return
+8.02%
1 Year Est. Return
+35.17%
3 Year Est. Return
+90.08%
5 Year Est. Return
+122.79%
10 Year Est. Return
+440.32%
AUM
$129M
AUM Growth
+$1.1M
Cap. Flow
-$8.51M
Cap. Flow %
-6.62%
Top 10 Hldgs %
25.77%
Holding
122
New
5
Increased
21
Reduced
65
Closed
8

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$1.33M
2
JPM icon
JPMorgan Chase
JPM
+$871K
3
LLY icon
Eli Lilly
LLY
+$776K
4
CATC
CAMBRIDGE BANCORP
CATC
+$628K
5
DVA icon
DaVita
DVA
+$539K

Sector Composition

Rank Sector Weight
1 Financials 30.92%
2 Healthcare 15.99%
3 Energy 14.58%
4 Consumer Discretionary 10.93%
5 Industrials 10.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TBBK icon
1
The Bancorp
TBBK
$2.79B
$5.3M 4.12%
158,437
-7,368
-4% -$293K
NVR icon
2
NVR
NVR
$17.2B
$4.19M 3.26%
517
-23
-4% -$171K
CVX icon
3
Chevron
CVX
$388B
$3.07M 2.39%
19,473
-2,651
-12% -$400K
TFIN icon
4
Triumph Financial Inc
TFIN
$1.84B
$3.02M 2.35%
38,039
+2,386
+7% +$180K
LEN icon
5
Lennar Class A
LEN
$20.4B
$3M 2.33%
18,024
-971
-5% -$146K
GE icon
6
GE Aerospace
GE
$367B
$2.94M 2.29%
20,974
-1,264
-6% -$149K
ABBV icon
7
AbbVie
ABBV
$458B
$2.89M 2.25%
15,892
-800
-5% -$138K
LLY icon
8
Eli Lilly
LLY
$1.07T
$2.79M 2.17%
3,586
-1,091
-23% -$776K
MRK icon
9
Merck
MRK
$324B
$2.73M 2.12%
20,681
-2,284
-10% -$282K
C icon
10
Citigroup
C
$222B
$2.45M 1.91%
38,770
-464
-1% -$25.8K
MGM icon
11
MGM Resorts International
MGM
$11.7B
$2.37M 1.84%
50,115
-2,625
-5% -$115K
FANG icon
12
Diamondback Energy
FANG
$57.6B
$2.35M 1.83%
11,860
-865
-7% -$147K
PFE icon
13
Pfizer
PFE
$140B
$2.3M 1.79%
82,762
+14,618
+21% +$406K
BMY icon
14
Bristol-Myers Squibb
BMY
$127B
$2.29M 1.78%
42,147
+3,145
+8% +$160K
COP icon
15
ConocoPhillips
COP
$147B
$2.26M 1.76%
17,762
-1,805
-9% -$206K
MMM icon
16
3M
MMM
$89B
$2.23M 1.74%
25,171
+10,687
+74% +$886K
IRM icon
17
Iron Mountain
IRM
$38.2B
$2.14M 1.66%
26,687
BRK.B icon
18
Berkshire Hathaway Class B
BRK.B
$1.07T
$2.13M 1.66%
5,069
-1,205
-19% -$474K
TROW icon
19
T. Rowe Price
TROW
$25B
$2.13M 1.66%
17,465
+170
+1% +$19K
VBTX
20
DELISTED
Veritex Holdings
VBTX
$1.96M 1.53%
95,735
+6,435
+7% +$133K
PXD
21
DELISTED
Pioneer Natural Resource Co.
PXD
$1.77M 1.37%
6,727
-228
-3% -$53.5K
CTRA
22
DELISTED
Coterra Energy
CTRA
$1.76M 1.37%
63,110
-2,475
-4% -$63.5K
OMF icon
23
OneMain Financial
OMF
$6.9B
$1.7M 1.32%
33,329
+25
+0.1% +$1.19K
RTX icon
24
RTX Corp
RTX
$287B
$1.7M 1.32%
17,415
-318
-2% -$28.7K
BANC icon
25
Banc of California
BANC
$3.28B
$1.7M 1.32%
111,485
-1,900
-2% -$26.4K

Similar funds

Sippican Capital Advisors's Q1 2024 Portfolio in Review

As of Q1 2024, Sippican Capital Advisors held 122 positions worth $129M, up 0.86% from $127M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Sippican Capital Advisors withdrew a net $8.51M in Q1 2024, closing 8 positions and reducing 65 holdings. Its most notable exit was PHYSICIANS REALTY TRUST, an estimated $516K position sold in full.

By sector, the portfolio is most concentrated in Financials at 31% of assets, down from 32% a quarter earlier, followed by Healthcare and Energy.

Against the trend, Sippican Capital Advisors opened a new position in Healthpeak Properties worth $686K.

  • Sippican Capital Advisors's largest Q1 2024 buy was Healthpeak Properties: 36,564 shares worth $686K.
  • Sippican Capital Advisors added most to Columbia Banking Systems in Q1 2024, an estimated $1.15M increase.
  • Sippican Capital Advisors's biggest Q1 2024 reduction was Gilead Sciences, cutting an estimated $1.33M.
  • Sippican Capital Advisors fully exited PHYSICIANS REALTY TRUST in Q1 2024, selling an estimated $516K.
  • Sippican Capital Advisors's ten largest holdings make up 26% of its $129M portfolio in Q1 2024.
  • Sippican Capital Advisors opened 5 new positions and closed 8 in Q1 2024.
  • Sippican Capital Advisors's portfolio value rose 0.86% quarter-over-quarter to $129M.

Based on Sippican Capital Advisors's 13F filing for Q1 2024, filed 2 May 2024.